A new tool, a better tool? Prevalence and performance of the International Diabetes Federation and the National Cholesterol Education Program criteria for metabolic syndrome in different ethnic groups

被引:24
作者
Bindraban, N. R. [1 ,3 ]
van Valkengoed, I. G. M. [1 ]
Mairuhu, G. [2 ]
Koster, R. W. [3 ]
Holleman, F. [2 ]
Hoekstra, J. B. L. [2 ]
Koopmans, R. P. [2 ]
Stronks, K. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Social Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands
关键词
ehnicity; metabolic syndrome; cardiovascular disease;
D O I
10.1007/s10654-007-9200-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We used a population based study in the Netherlands of 330 Hindustani Surinamese, 586 African Surinamese, and 486 ethnic Dutch (Dutch) to describe the prevalence of the metabolic syndrome (MS) and the association with differences in cardiovascular disease in and between ethnic groups. Fasting blood samples, blood pressure, and anthropometric measurements were obtained. MS was defined according to the criteria of the International Diabetes Federation (IDF) and the criteria of the National Cholesterol Education Program (NCEP). Cardiovascular disease was assessed by the Rose questionnaire and included questions on previous diagnoses of angina pectoris/myocardial infarction, cerebrovascular accident, intermittent claudication. The prevalence of MS (IDF and NCEP) was highest in Hindustani Surinamese men, followed by Dutch and African Surinamese men: 51.0%, 19.4%, and 31.2% (IDF), respectively. Among women, both the Hindustani and African Surinamese participants had a higher prevalence of MS (IDF and NCEP) than the Dutch. The association between the components, MS and cardiovascular disease differed between ethnic groups, in particular among men; OR for MS (NCEP) = 1.0 (0.4-2.7) among Hindustani Surinamese, OR = 4.9 (1.3-18.3) among African Surinamese, and OR = 2.8 (1.1-7.1) among Dutch. However, the differences in MS could not account for the ethnic differences in cardiovascular disease, regardless of the criteria used. The results suggest that, before the criteria can be used to guide practice, they may need to be changed and refined to take into account the differences between ethnic groups as well as the variations by gender.
引用
收藏
页码:37 / 44
页数:8
相关论文
共 22 条
[11]   Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women [J].
Hu, G ;
Qiao, Q ;
Tuomilehto, J ;
Balkau, B ;
Borch-Johnsen, K ;
Pyorala, K .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (10) :1066-1076
[12]   National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study [J].
Hunt, KJ ;
Resendez, RG ;
Williams, K ;
Haffner, SM ;
Stern, MP .
CIRCULATION, 2004, 110 (10) :1251-1257
[13]   Cardiovascular morbidity and mortality associated with the metabolic syndrome [J].
Isomaa, B ;
Almgren, P ;
Tuomi, T ;
Forsén, B ;
Lahti, K ;
Nissén, M ;
Taskinen, MR ;
Groop, L .
DIABETES CARE, 2001, 24 (04) :683-689
[14]   Screening for silent coronary heart disease in type 2 diabetes - Clinical application of American Diabetes Association guidelines [J].
Kharlip, J ;
Naglieri, R ;
Mitchell, BD ;
Ryan, KA ;
Donner, TW .
DIABETES CARE, 2006, 29 (03) :692-694
[15]   The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men [J].
Lakka, HM ;
Laaksonen, DE ;
Lakka, TA ;
Niskanen, LK ;
Kumpusalo, E ;
Tuomilehto, J ;
Salonen, JT .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (21) :2709-2716
[16]   RELATION OF CENTRAL OBESITY AND INSULIN RESISTANCE WITH HIGH DIABETES PREVALENCE AND CARDIOVASCULAR RISK IN SOUTH ASIANS [J].
MCKEIGUE, PM ;
SHAH, B ;
MARMOT, MG .
LANCET, 1991, 337 (8738) :382-386
[17]   ROLE OF INSULIN RESISTANCE IN HUMAN-DISEASE [J].
REAVEN, GM .
DIABETES, 1988, 37 (12) :1595-1607
[18]   C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events [J].
Ridker, PM ;
Buring, JE ;
Cook, NR ;
Rifai, N .
CIRCULATION, 2003, 107 (03) :391-397
[19]  
ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645
[20]   Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study [J].
Sattar, N ;
Gaw, A ;
Scherbakova, O ;
Ford, I ;
O'Reilly, DS ;
Haffner, SM ;
Isles, C ;
Macfarlane, PW ;
Packard, CJ ;
Cobbe, SM ;
Shepherd, J .
CIRCULATION, 2003, 108 (04) :414-419